Skip navigation
Watchlist Sponsored By :

Current DateTime: 03:31:21 27 Nov 2009
LinksList Documentid: 24355697
  • Runway Angels

      The superbowl of fashion shows, models walk down the runway at the 2009 Victoria's Secret Show.

  • Smartphone Guide

      Here's a need-to-know guide to nine devices, based on features, price, network and platform.

  • Wines for the Holidays

      Not quite sure what wine to pair with Turkey or Creme Brulee? Our experts do.

FEATURED QUIZZES


Current DateTime: 03:31:22 27 Nov 2009
LinksList Documentid: 33793611
  • How Well Do You Know Your Bird?

      Let's talk turkey. Test your turkey knowledge and perhaps pick up a bit of trivia to trot out at your holiday meal.

  • A Healthier & Wealthier You

      Take the following quiz and find out how much you know about the impact of obesity on the health of the U.S. economy.

  • The Billionaire BFF's

      Philanthropists. Bridge partners. Hockey players. Which responses are based on facts from Buffett's and Gates' real lives?


Current DateTime: 03:31:22 27 Nov 2009
LinksList Documentid: 24890560
  • Winterizing Your Portfolio

      If 2009 was the winter of our discontent, will 2010 be a winter wonderland for investors? A lot depends on the recovery—or lack thereof.

  • Investor's Guide to Real Estate

      Some even say the long-awaited recovery is here. Regardless, buyers and sellers alike can profit from our guide.

  • Alternative Investing

      Stocks and bonds? Sure. But it's a big world out there for investors.

powered by digg
Roche Wins Ventana with Raised $3.4 Billion Bid
By: Reuters | 22 Jan 2008 | 03:31 AM ET
Text Size

Roche Holding has overcome Ventana's resistance to its takeover bid by raising its price, acquiring the diagnostics maker for $3.4 billion to boost its cancer testing business.

Roche said on Tuesday it would increase the tender offer for all outstanding Ventana Medical Systems [VMSI  Loading...      ()   ] shares to $89.50 per share in cash, from $75 per share.

Ventana had repeatedly rebuffed Roche's original bid, calling the offer grossly inadequate, but agreed to open its books to the Swiss company in November.

"The transaction with Roche at $89.50 per share is in the best interests of our shareholders, and we recommend that our shareholders tender into this revised offer," Ventana chief Christopher Gleeson, who will remain as CEO of the business after the deal, said in the statement.

Roche shares were indicated roughly 2 percent lower at 190 francs per share in pre-market data.

Roche's diagnostics head, Severin Schwan, said the deal would have minimal impact on group margins and earnings per share.

Roche said it would amend its existing tender offer to acquire all outstanding Ventana shares, and the offer would expire on February 7.

Roche has ended up paying a significant premium to recent deals to secure Tucson, Arizona-based Ventana, which the Swiss firm sees as a particularly good fit as it makes tests which could speed up detection of cancer and enhance use of targeted therapies, such as Roche's blockbuster drug Herceptin.

Ventana shares rocketed after Roche made its initial cash offer in June 2007, pitched at a 44 percent premium to what investors had previously thought the company was worth.

Ventana shares have remained above $75 since and closed at $85.33 on Friday, when U.S. markets were last open.

The $75 offer already valued Ventana at a higher multiple than other recent similar deals, including Inverness Medical Innovations's purchase of Biosite and Qiagen's acquisition of Digene.

The original bid valued Ventana at 8.6 times expected 2008 sales, according to data from analyst Bruce Cranna at Leerink Swann, versus 4.6 for Biosite and 6.5 for Digene.

But that is unlikely to cause ripples at cash-rich Roche, which had 24.2 billion Swiss francs ($21.96 billion) in cash at the end of 2006.

Roche, which has made a number of deals to boost its diagnostics unit in the last year, said it will continue to screen that area for more small and mid-sized acquisitions and collaborations.

Copyright 2009 Reuters. Click for restrictions.
Tools:
Print EmailAdd This share icon
  • digg share

CNBC HIGHLIGHTS

  • Social enterprises are becoming a new asset class for the ethically-minded.
  • Ever wished your cab driver would stop nattering and just get to where you're going? Well that moment is near(er).
  • Bill Griffeth is taking a leave of absence from CNBC and Power Lunch for a year. Here's a message from Bill.
  • More shoppers than ever plan to comparison-shop this season. Who will benefit?
  • It may be the most unusual guide to business you'll read.
ADD COMMENTS
Remaining characters


Current DateTime: 02:07:17 27 Nov 2009
LinksList Documentid: 29778428

Current DateTime: 01:02:03 27 Nov 2009
LinksList Documentid: 29779196

Current DateTime: 01:03:47 27 Nov 2009
LinksList Documentid: 29779199

Current DateTime: 01:03:47 27 Nov 2009
LinksList Documentid: 29779198
  Data is a real-time snapshot  *Data is delayed at least 15 minutes
Global Business and Financial News, Stock Quotes, and Market Data and Analysis

© 2009 CNBC, Inc.  All Rights Reserved.
A Division of NBC Universal
Thomson ReutersThomson Reuters